S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 83 200 KRW -2.92% Market Closed
Market Cap: 1.7T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ST Pharm Co Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Current Portion of Long-Term Debt
â‚©9.4B
CAGR 3-Years
157%
CAGR 5-Years
105%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Current Portion of Long-Term Debt
â‚©822.8B
CAGR 3-Years
356%
CAGR 5-Years
25%
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Current Portion of Long-Term Debt
â‚©56.4B
CAGR 3-Years
148%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Current Portion of Long-Term Debt
â‚©1.1B
CAGR 3-Years
32%
CAGR 5-Years
22%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Current Portion of Long-Term Debt
â‚©268.6m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Current Portion of Long-Term Debt
â‚©28.6B
CAGR 3-Years
323%
CAGR 5-Years
149%
CAGR 10-Years
N/A
No Stocks Found

ST Pharm Co Ltd
Glance View

Market Cap
1.6T KRW
Industry
Life Sciences Tools & Services

ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. The company is headquartered in Siheung, Gyeonggi-Do. The company went IPO on 2016-06-23. is a Korea-based company principally engaged in manufacture of pharmaceutical products. The firm's products mainly consist of generic active pharmaceutical ingredients (APIs), such as tipepidine hibenzate, doxifluridine, clopidogrel bisulfate, voriconazole and new medicine APIs, such as small molecule APIs. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
97 768.06 KRW
Undervaluation 15%
Intrinsic Value
Price
S

See Also

What is ST Pharm Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
9.4B KRW

Based on the financial report for Sep 30, 2024, ST Pharm Co Ltd's Current Portion of Long-Term Debt amounts to 9.4B KRW.

What is ST Pharm Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
105%

Over the last year, the Current Portion of Long-Term Debt growth was -90%. The average annual Current Portion of Long-Term Debt growth rates for ST Pharm Co Ltd have been 157% over the past three years , 105% over the past five years .

Back to Top